Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naïve social phobia patients - Test2 - elhamkhani - TriplyDB

Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naïve social phobia patients

Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naïve social phobia patients

http://www.wikidata.org/entity/Q24611774

about

Does Cannabidiol Protect Against Adverse Psychological Effects of THC?Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders Beyond THC: The New Generation of Cannabinoid Designer Drugs Cannabidiol: pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders Pharmacological treatment of anxiety disorders: current treatments and future directions Human experimental anxiety: actual public speaking induces more intense physiological responses than simulated public speaking Early Phase in the Development of Cannabidiol as a Treatment for Addiction: Opioid Relapse Takes Initial Center Stage.Emerging drugs for the treatment of anxiety Fluorinated Cannabidiol Derivatives: Enhancement of Activity in Mice Models Predictive of Anxiolytic, Antidepressant and Antipsychotic Effects.Distinct neurobehavioural effects of cannabidiol in transmembrane domain neuregulin 1 mutant mice.Endocannabinoid system and psychiatry: in search of a neurobiological basis for detrimental and potential therapeutic effects.Inverted U-Shaped Dose-Response Curve of the Anxiolytic Effect of Cannabidiol during Public Speaking in Real Life.A single dose of cannabidiol reduces blood pressure in healthy volunteers in a randomized crossover study.Plant-based medicines for anxiety disorders, part 2: a review of clinical studies with supporting preclinical evidence.Cannabinoids in experimental stroke: a systematic review and meta-analysis.Cannabidiol as a Potential Treatment for Anxiety Disorders.Current Status and Prospects for Cannabidiol Preparations as New Therapeutic Agents.Plastic and Neuroprotective Mechanisms Involved in the Therapeutic Effects of Cannabidiol in Psychiatric Disorders.Pharmacological interventions in the treatment of the acute effects of cannabis: a systematic review of literature Mitigation of post-traumatic stress symptoms by Cannabis resin: a review of the clinical and neurobiological evidence.Cannabidiol in humans-the quest for therapeutic targets Beyond the CB1 Receptor: Is Cannabidiol the Answer for Disorders of Motivation?A protocol for the delivery of cannabidiol (CBD) and combined CBD and ∆9-tetrahydrocannabinol (THC) by vaporisation The Medicinal Cannabis Treatment Agreement: Providing Information to Chronic Pain Patients Through a Written Document.Social anxiety and cannabis use: an analysis from ecological momentary assessment.Rimonabant effects on anxiety induced by simulated public speaking in healthy humans: a preliminary report.HU-444, a Novel, Potent Anti-Inflammatory, Nonpsychotropic Cannabinoid.Failure to extinguish fear and genetic variability in the human cannabinoid receptor 1.Alcohol and cannabis use among college students: Substitutes or complements?Neural correlates of interactions between cannabidiol and Δ(9) -tetrahydrocannabinol in mice: implications for medical cannabis.Assessing public speaking fear with the short form of the Personal Report of Confidence as a Speaker scale: confirmatory factor analyses among a French-speaking community sample.Cannabinoid-related agents in the treatment of anxiety disorders: current knowledge and future perspectives.Impact of enzymatic and alkaline hydrolysis on CBD concentration in urine.Oral Cannabidiol does not Alter the Subjective, Reinforcing or Cardiovascular Effects of Smoked Cannabis.The endocannabinoid system as a possible target to treat both the cognitive and emotional features of post-traumatic stress disorder (PTSD)Instruments for the assessment of social anxiety disorder: Validation studies.Cannabis craving in response to laboratory-induced social stress among racially diverse cannabis users: The impact of social anxiety disorder.A Systematic Review and Meta-Analysis of the Haemodynamic Effects of Cannabidiol.Cannabidiol for neurodegenerative disorders: important new clinical applications for this phytocannabinoid?Cannabidiol, a Cannabis sativa constituent, as an anxiolytic drug.

P2860

Q21129107-A1E113D6-5888-4ADB-B17F-573697EAC784 Q24623179-93A9D45A-3310-4DD3-A38E-C261424726F7 Q24635230-378E2384-65AC-4E58-AF61-C2C00D3C06C6 Q26823267-D1AF85C4-9E39-44A7-8F4B-306DF7346713 Q26851461-90C93B53-D539-468F-89D5-9D6491BCFC3D Q27014111-79476368-0ACA-4C5D-8D5D-EDBA91CED572 Q27336497-622F0D5F-314A-417A-9A88-F2AED17524F3 Q28083141-0BBC2BEA-E47F-469A-831A-66F9F3C01E4F Q30376980-A80609FC-9010-4F77-9125-63EC6B345224 Q30468504-ED02DC55-A114-443C-B897-76A89F1E3572 Q30473707-8F029E14-2AFE-42EA-9AC5-3472A62059EC Q33658933-B1C39E09-1F2F-437A-A959-A5855E687383 Q33798050-2A3C78E8-6757-448C-82AD-5C523DAF09CD Q34343456-4A5A57CD-21B0-4D02-BD4E-6670D74EC50F Q34452972-F251B884-554C-40AA-A856-3DB17E280E1C Q34492624-40C97B85-8783-434A-990B-2CE7BDFF6758 Q34530386-6FE47EFF-0B20-493E-85D1-276068AB74AF Q34557613-17BA8121-D19C-47E5-B301-EE708257C624 Q34635342-1ED75EF3-DDB4-45B0-8DD1-CF332F6484D8 Q34639648-58C73BD5-BF9D-4E57-85AA-1084686D076B Q34657897-89A22174-95DD-4D4C-9BB8-C9EDDB330F97 Q34676610-BFE8E17F-1FD5-47D2-B388-9AFA23D9C313 Q34762272-63133BFA-23B2-4346-A28C-3A34FF2863AC Q35563620-B98D18F7-051F-47D0-B84B-90E0F9E9A0D3 Q35713299-358A374F-20AC-4843-88D2-F99D8B8F95C8 Q35962896-EEF2263D-AF2F-4190-A155-7F57A3783912 Q36077672-ABB1FA55-50C2-49DC-A323-8BF30BD6113E Q36589751-2863BF3B-5B49-4E1E-AADE-AA33DAF2E6D1 Q36730858-EBA7FDD1-FAD9-4EED-A418-4693F371B977 Q36744227-EADD2C9F-84AA-423E-BDDE-70C70DB4A604 Q36825052-9DAF2906-A788-406D-8CBC-5500B38083FA Q36953261-E476D488-DEC9-43EF-8BBA-555726319E2E Q36987924-435D1A5C-76F4-46AD-9967-97642B747AD2 Q37006281-398DD723-4914-41E8-A420-68AF07BDCBFC Q37083923-87EF4233-6223-4480-8CEF-CD2E7A520059 Q37195300-0C074DFD-9952-423E-8DF3-6D069E366975 Q37488932-FE23C9AF-DEC7-40CB-9C7C-C6F2E9B22FE2 Q37662551-227E5344-058D-42F6-B0EE-EC21D72AFFB2 Q38012845-51719CDD-77D5-4E36-88EB-431C15F0BDCE Q38021373-15A80657-27B4-47DA-99C6-7FA617F83BC0

P2860

Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naïve social phobia patients

http://www.wikidata.org/entity/Q24611774

description

2011 nî lūn-bûn

@nan

2011 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Cannabidiol reduces the anxiet ...... t-naïve social phobia patients

@ast

Cannabidiol reduces the anxiet ...... t-naïve social phobia patients

@en

Cannabidiol reduces the anxiet ...... t-naïve social phobia patients

@nl

type

label

Cannabidiol reduces the anxiet ...... t-naïve social phobia patients

@ast

Cannabidiol reduces the anxiet ...... t-naïve social phobia patients

@en

Cannabidiol reduces the anxiet ...... t-naïve social phobia patients

@nl

prefLabel

Cannabidiol reduces the anxiet ...... t-naïve social phobia patients

@ast

Cannabidiol reduces the anxiet ...... t-naïve social phobia patients

@en

Cannabidiol reduces the anxiet ...... t-naïve social phobia patients

@nl

P1433

Q24611774-B80898C6-232C-4E26-860E-7788055F9BBF

P1476

Q24611774-F36DE8B4-CD6C-4239-AB12-880693DF709E

P2093

Q24611774-24B5496F-852B-4B42-B491-89113A8F6B84

Q24611774-2BEED69A-70FD-4236-AFD7-4D21AA1E3EEA

Q24611774-957D9D97-06EE-4E2A-B870-27F1839A4166

Q24611774-9DF5D0A6-C492-4B72-A057-D19A118B8853

Q24611774-A0559A10-AFA4-4A2F-ACA2-48380A2826F5

Q24611774-A87D0122-1587-4755-AA12-3C9A809FBDC2

Q24611774-CD60DF9D-1279-407D-97F8-7056308D6A4A

Q24611774-E69E2BB8-C0B0-4AF8-BD3A-5F1286E1E149

Q24611774-E815626F-A624-4CFC-887A-16B317BD49EC

Q24611774-EA979CE5-60FD-4961-AF94-5F7768210276

P2860

Q24611774-00230D42-0A23-47BC-9166-6696A855F7EA

Q24611774-0EDE6971-8F3C-45D4-BC00-A60410A056D6

Q24611774-0FC446CF-115B-4D2B-BDF3-33ED003534A0

Q24611774-1485BB6F-E4E7-4229-B98C-AF24F3E1814A

Q24611774-1EE63DC0-A279-4960-86B2-1E6BBCFFCA1E

Q24611774-1FC1B0A5-D2D6-477C-BC2D-C9B7B2948420

Q24611774-20BE8A01-21D4-4EB5-8FC0-64CFDC7D4783

Q24611774-245CDC67-FEFC-465D-BA34-854BB74FA64E

Q24611774-26DAAEFB-CE9F-4921-AA62-F9B5319334E1

Q24611774-3454FF5E-B126-4A44-980F-A77A672A2783

P2888

Q24611774-63810CA7-4D75-42C4-80B7-FF527B1E27DF

P304

Q24611774-9C19EA4D-3DA4-4A1F-8C04-3203EF3E1BB8

P31

Q24611774-82B83549-AB0B-49A3-A9A5-0C3B8C33E891

P3181

Q24611774-467538F1-68DE-4BB3-A98D-133DBF50F919

P356

Q24611774-7371BDD4-2A2D-407A-8D68-3F9BE3E12D60

P407

Q24611774-4A2ACA6B-56F2-4525-8A2D-9B3F7EF0F0A9

P433

Q24611774-09008C24-088E-4C97-86DD-1D5F5C8A8AE6

P478

Q24611774-181C5DDA-D6EB-465F-9052-8EDAE4E7D7CA

P50

Q24611774-0BDAC044-D2C1-4E07-B080-802B3716E1BB

Q24611774-39373E56-F373-4CE7-A85D-1A26A2B44809

Q24611774-DE8FF526-06AB-4658-8DD3-99DE6BF7C8C5

Q24611774-FDA7F9DF-4D0B-4736-A483-C093D5DBA612

P577

Q24611774-A5355656-7E2D-4712-A959-78CA709ABFDE

P5875

Q24611774-D7BFE78F-DEF2-4421-B5C8-0AD8EE0E517C

P6179

Q24611774-14B90CE0-C114-4AB8-92CF-1DE4CC56FF63

P698

Q24611774-07E1244B-4894-4E15-87C3-69FA4AC34098

P921

Q24611774-61F17BD7-B634-4960-AFDF-E35B4E701CE8

Q24611774-661BFEFE-5CC1-4E2D-ABF3-488E665574F7

Q24611774-A7E56AA8-F9AF-4BEC-B03F-074F4D53B59A

P932

Q24611774-FB8134F4-C81D-40F0-AB28-7E712E991BCD

P3181

P356

P1433

Neuropsychopharmacology

P1476

Cannabidiol reduces the anxiet ...... t-naïve social phobia patients

@en

P2093

Antonio E Nardi

http://www.w3.org/2001/XMLSchema#string

Antonio Waldo Zuardi

http://www.w3.org/2001/XMLSchema#string

Danielle Chaves Gomes de Oliveira

http://www.w3.org/2001/XMLSchema#string

Flávio Kapczinski

http://www.w3.org/2001/XMLSchema#string

Jaime Eduardo Cecílio Hallak

http://www.w3.org/2001/XMLSchema#string

José Alexandre S Crippa

http://www.w3.org/2001/XMLSchema#string

Marcos Hortes Nisihara Chagas

http://www.w3.org/2001/XMLSchema#string

Mateus M Bergamaschi

http://www.w3.org/2001/XMLSchema#string

Regina Helena Costa Queiroz

http://www.w3.org/2001/XMLSchema#string

Rocio Martín-Santos

http://www.w3.org/2001/XMLSchema#string

P2860

Cannabidiol, a nonpsychotropic component of cannabis, inhibits cue-induced heroin seeking and normalizes discrete mesolimbic neuronal disturbances

Treatment of social phobia with antidepressants.

Psychometric properties of the Social Phobia Inventory (SPIN). New self-rating scale.

Social phobia: diagnosis and epidemiology, neurobiology and pharmacology, comorbidity and treatment.

Specificity of social anxiety disorder as a risk factor for alcohol and cannabis dependence

Cannabidiol attenuates the appetitive effects of Delta 9-tetrahydrocannabinol in humans smoking their chosen cannabis

Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report.

Action of cannabidiol on the anxiety and other effects produced by delta 9-THC in normal subjects.

Effects of cannabidiol (CBD) on regional cerebral blood flow.

Agonistic properties of cannabidiol at 5-HT1a receptors.

P2888

P304

1219-1226

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4551533

http://www.w3.org/2001/XMLSchema#string

P356

10.1038/NPP.2011.6

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

36

http://www.w3.org/2001/XMLSchema#string

P50

Bruno S De Martinis

P577

2011-02-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49823570

http://www.w3.org/2001/XMLSchema#string

P6179

1047541455

http://www.w3.org/2001/XMLSchema#string

P698

21307846

http://www.w3.org/2001/XMLSchema#string

P921

P932

3079847

http://www.w3.org/2001/XMLSchema#string